Cancer Biomarkers: Clinical Aspects and Laboratory Determination

Herausgeber: Ramanathan, Lakshmi V; Duffy, Michael J; Fleisher, Martin

• Broschiertes Buch

Produktbeschreibung

Cancer Biomarkers: Clinical Aspects and Laboratory Determination provides a comprehensive overview of current biomarkers for cancer detection, monitoring and recurrence, focusing on emerging technologies, impacts on the field, and selected biomarkers currently used in clinical practice. The content highlights current laboratory tests used in the management of adult and pediatric cancer patients. In addition, it investigates the role of Circulating Tumor Cells and circulating tumor DNA as biomarkers in cancer management as well as cytokines in monitoring response to CAR T therapies. This title is a perfect reference for clinical pathologists, laboratory scientists, medical technologists, physicians specializing in oncology, internal medicine, family practice and transplant medicine, resident physicians, medical students, nurse practitioners and clinical chemists.

Produktdetails

• Clinical Aspects and Laboratory Determination
• Verlag: Elsevier Science Publishing Co Inc
• Seitenzahl: 474
• Erscheinungstermin: 15. Juni 2022
• Englisch
• Abmessung: 190mm x 233mm x 32mm
• Gewicht: 952g
• ISBN-13: 9780128243022
• ISBN-10: 0128243023
• Artikelnr.: 62926014

Inhaltsangabe

1. Overview of tumor markers, traditional and non-traditional (include
glycans)
2. Laboratory testing in pediatric cancer patients
3. The adult cancer patient: overview and current laboratory testing
4. Thyroglobulin measurement: its importance in monitoring and recurrence
of thyroid cancer
5. PSA, long term prognosis
6. Monoclonal gammopathy detection and current technologies
7. Liquid biopsy potential and challenges
8. CAR T therapies and the management of toxicity
9. Validating circulating tumor cells and cell free DNA as an LDT for use
in the clinic
10. Saliva as a matrix for measurement of biomarkers
11. Emerging technologies in the detection and monitoring of cancer
12. Oncometabolites
13. Circulating cancer biomarkers: current status and future prospects